Glycobiology Market Globally Grow at a CAGR of 13% by 2023: AGILENT TECHNOLOGIES, BRUKER CORPORATION, DANAHER CORPORATION, MERCK KGAA, NEW ENGLAND BIOLABS

The Glycobiology market is expected to register a CAGR of around 13%, during the forecast period, 2018 to 2023. Glycobiology is an important field in life sciences and involves the study of glycans that play diverse roles in study of bacterial physiology, novel drugs development, and proteomics research. Various technologies, such as mass spectrometry, MALDI-TOF, etc are used by researchers for glycomics application. Thus, the demand for glycobiology instruments, including mass spectrometers and MALDI-TOF mass spectrometry, is expected to increase in the near future.

Get your sample report now @ https://marketprognosis.com/sample-request/17047
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Growing R&D Expenditure by Pharmaceutical and Biotech Companies
The major pharmaceutical and biotech companies are investing heavily into the research and development of superior biological products, such as glycobiology products and products related to proteomics. Glycobiology or complex carbohydrates can be used for a variety of physiological processes such as signal transduction to tissue development. These properties make a glycobiology an attractive option for big pharma and biotech companies to invest in. Along with this other factor, such as increasing government and private funding for glycomics and proteomics will act as drivers for the glycobiology market. Other factor, such as increasing government and private funding for glycomics and proteomics research will also help boost market growth.

Key Developments in the Market
• February 2017 - Siliq (brodalumab) a drug developed using glycobiology from Valeant Pharmaceuticals was approved by the FDA for the treatment of plaque psoriasis
• February 2017 - Rhofade (oxymetazoline hydrochloride) a drug developed using glycomicsfrom Allergan was approved by the FDA for the treatment of facial erythema associated with rosacea

Major players:
AGILENT TECHNOLOGIES, BRUKER CORPORATION, DANAHER CORPORATION, MERCK KGAA, NEW ENGLAND BIOLABS, PROZYME, SHIMADZU CORPORATION, TAKARA BIO, THERMO FISHER SCIENTIFIC, WATERS CORPORATION, amongst others.

Get Discount on this report @ https://marketprognosis.com/discount-request/17047
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

High Product Cost
Huge amount of investment is put into development of products involving glycobiology. Also, the approval of drugs that are developed require lot of regulatory stages that need for process. This, in turn, renders these products very expensive. Patients and physicians may not be interested in such expensive alternatives and this in turn may become a restraining factor for the market of glycobiology. Along with this, the lack of availability of skilled professionals in the field of proteomics ad glycomics may act as a restraining factor for the growth of the market for glycobiology. Other factor, such as low availability of skilled professionals will lead to a slowdown in the growth of the glycobiology market

Maximum Growth to be witnessed by the North American Market
North America is expected to lead the global market. The easy accessibility to healthcare, affordable healthcare, and high rate of adoption about health care analytics and disorders amongst the overall population is projected to drive the regional market. The glycobiology market is also see a substantial rise as the region has a strong presence of the largest pharmaceutical companies and high demand for novel drugs and biotechnological products. In the APAC region the ever-increasing pool of geriatrics is anticipated to drive these regional markets. Asia-Pacific will grow at a considerable rate in the global market during the forecast period. The increasing expenditure on healthcare in the emerging economies is expected to be pivotal to this regional market’s growth.

For More Information, Please Visit @ https://marketprognosis.com/enquiry/17047
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMark Pvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.